Implanet【ALIMP】銘柄情報

Implanet (ALIMP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.168

( 1.94% )

買値

0.168

売値

0.1758

出来高

95,621

0.1622 日の範囲 0.182

0.15 52 週間の範囲 0.45

時価総額

24.162M

前日終値

0.1648

始値

0.1622

時刻

156

0.168

最終取引時間

20:10:56

財務取引量

VWAP

平均取引量 (3 か月)

85,649 €

発行済株式数

143,818,971

配当利回り

PER

-4.96

1 株当たり利益 (EPS)

-0.03

歳入

12.47M

純利益

-4.38M

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jaz... Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The company exports its products. Implanet S.A. was founded in 2006 and is headquartered in Martillac, France. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.implanet.com

本社

Martillac, France

設立

2026

Implanet is listed in the Healthcare sector of the ユーロネクスト with ticker ALIMP. The last closing price for Implanet was 0.16 €. Over the last year, Implanet shares have traded in a share price range of 0.15 € to 0.45 €.

Implanet currently has 143,818,971 shares in issue. The market capitalisation of Implanet is 24.16 € million. Implanet has a price to earnings ratio (PE ratio) of -4.96.

IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for...

IMPLANET annonce un chiffre d’affaires semestriel 2025 en hausse de +41% à 5,8 M€

Croissance du deuxième trimestre 2025 de +71% à 3,2 M€ Une activité aux Etats-Unis multipliée par 5,4 sur le deuxième trimestre et par 1,7 sur...

IMPLANET to Co-Exhibit its Innovative Spine Solutions Alongside 8i Robotics’ Next-Gen Robotic Solutions at AANS in Boston

Spine tech innovator IMPLANET will demo and display its game-changing portfolio in tandem with 8i Robotics’ robot systems at Booth #1029, April...

Compte rendu de l’Assemblée Générale Mixte d’IMPLANET du 11 avril 2025

Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), société de technologies médicales spécialisée dans les...

IMPLANET Reports Revenue of €2.58 Million in Q1 2025, Up +16%

+16% revenue growth compared to Q1 2024 Performance driven by strong export growth outside France and the United States (+42% vs. Q1 2024...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.002	-1.17647058824	0.17	0.182	0.15	169093	0.1653945	DE
4	-0.0248	-12.8630705394	0.1928	0.1938	0.15	89294	0.17499939	DE
12	-0.0425	-20.190023753	0.2105	0.2325	0.15	86999	0.19242263	DE
26	-0.048	-22.2222222222	0.216	0.286	0.15	139253	0.21799252	DE
52	0.008	5	0.16	0.45	0.15	319718	0.26230091	DE
156	-0.0138	-7.59075907591	0.1818	0.45	0.035	216733	0.16968949	DE
260	-0.673	-80.0237812128	0.841	0.89	0.035	207992	0.22612936	DE